Literature DB >> 23219930

Generation of dried tube specimen for HIV-1 viral load proficiency test panels: a cost-effective alternative for external quality assessment programs.

Artur Ramos1, Shon Nguyen, Albert Garcia, Shambavi Subbarao, John N Nkengasong, Dennis Ellenberger.   

Abstract

Participation in external quality assessment programs is critical to ensure quality clinical laboratory testing. Commercially available proficiency test panels for HIV-1 virus load testing that are used commonly in external quality assessment programs remain a financial obstacle to resource-limited countries. Maintaining cold-chain transportation largely contributes to the cost of traditional liquid proficiency test panels. Therefore, we developed and evaluated a proficiency test panel using dried tube specimens that can be shipped and stored at ambient temperature. This dried tube specimens panel consisted of 20 μl aliquots of a HIV-1 stock that were added to 2 ml tubes and left uncapped for drying, as a preservation method. The stability of dried tube specimens at concentrations ranging from 10² to 10⁶·⁵ RNA copies/ml was tested at different temperatures over time, showing no viral load reduction at 37 °C and a decrease in viral load smaller than 0.5 Log₁₀ at 45 °C for up to eight weeks when compared to initial results. Eight cycles of freezing-thawing had no effect on the stability of the dried tube specimens. Comparable viral load results were observed when dried tube specimen panels were tested on Roche CAPTAQ, Abbott m2000, and Biomerieux easyMAG viral load systems. Preliminary test results of dried proficiency test panels shipped to four African countries at ambient temperature demonstrated a low inter assay variation (SD range: 0.29-0.41 Log₁₀ RNA copies/ml). These results indicated that HIV-1 proficiency test panels generated by this methodology might be an acceptable alternative for laboratories in resource-limited countries to participate in external quality assessment programs. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 23219930     DOI: 10.1016/j.jviromet.2012.11.036

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Monitoring the quality of HIV-1 viral load testing through a proficiency testing program using dried tube specimens in resource-limited settings.

Authors:  Shon Nguyen; Artur Ramos; Joy Chang; Bin Li; Vedapuri Shanmugam; Debrah Boeras; John N Nkengasong; Chunfu Yang; Dennis Ellenberger
Journal:  J Clin Microbiol       Date:  2015-01-21       Impact factor: 5.948

2.  Development of dried tube specimens for Xpert MTB/RIF proficiency testing.

Authors:  Kyle DeGruy; Katherine Klein; Zilma Rey; Patricia Hall; Andrea Kim; Heather Alexander
Journal:  Afr J Lab Med       Date:  2020-09-29

Review 3.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

4.  The Development of a Standardized Quality Assessment Material to Support Xpert® HIV-1 Viral Load Testing for ART Monitoring in South Africa.

Authors:  Lara Dominique Noble; Lesley Erica Scott; Asiashu Bongwe; Pedro Da Silva; Wendy Susan Stevens
Journal:  Diagnostics (Basel)       Date:  2021-01-22

5.  Implementation of Novel Quality Assurance Program for Hepatitis C Viral Load Point of Care Testing.

Authors:  Wayne Dimech; Liza Cabuang; Kylie Davies; Giuseppe Vincini
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

6.  Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey.

Authors:  Robert A Domaoal; Katrina Sleeman; Souleymane Sawadogo; Tafadzwa Dzinamarira; Ndahafa Frans; Saara P Shatumbu; Ligamena N Kakoma; Terthu K Shuumbwa; Mackenzie Hurlston Cox; Sally Stephens; Lydia Nisbet; Melissa Metz; Suzue Saito; Daniel B Williams; Andrew C Voetsch; Hetal K Patel; Bharat S Parekh; Yen T Duong
Journal:  J Acquir Immune Defic Syndr       Date:  2021-08-01       Impact factor: 3.771

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.